A Review of the Barriers to Sharing in Biobanking

被引:20
作者
Colledge, Flora [1 ]
Elger, Bernice [1 ]
Howard, Heidi C. [2 ,3 ]
机构
[1] Univ Basel, Inst Biomed Eth, Basel, Switzerland
[2] Univ Toulouse, INSERM, UMR 1027, Dept Epidemiol & Publ Hlth, Toulouse, France
[3] Univ Toulouse, Fac Med Purpan, Toulouse, France
关键词
ETHICAL-ISSUES; BROAD CONSENT; NETWORKS; BENEFITS; BANKING; SOCIETY; SCIENCE; DONORS; LEGAL;
D O I
10.1089/bio.2013.0039
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although biobanks are gaining importance as tools in the field of biomedical research, enabling investigators to access large numbers of catalogued samples and/or data, most have not reached their full potential. Numerous obstacles may prohibit the efficient sharing of, and access to their sample and data collections. In order to minimize or overcome these obstacles while meeting ethical criteria, the first step is to identify the challenges to sharing between biobanks and between biobanks and researchers, thus enabling targeted solutions to be implemented. To date, no one has specifically catalogued the full scope of the barriers to sample sharing currently identified in the literature, yet such a list is essential if these matters are to be addressed. We have reviewed the literature on biobanks in order to identify the issues mentioned as barriers to sample sharing with or without data. Our literature search identified 15 barriers, including logistical, ethical, and legal issues. In this article, we provide a description of these barriers, discuss key themes, and conclude that empirical research is required to determine the full extent of the challenges addressed in the literature.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 56 条
  • [1] The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives
    Andersson, Kristin
    Bray, Freddie
    Arbyn, Marc
    Storm, Hans
    Zanetti, Roberto
    Hallmans, Goran
    Coebergh, Jan W.
    Dillner, Joakim
    [J]. ACTA ONCOLOGICA, 2010, 49 (08) : 1227 - 1234
  • [2] Asslaber Martin, 2007, Briefings in Functional Genomics & Proteomics, V6, P193, DOI 10.1093/bfgp/elm023
  • [3] BALLANTYNE C, 2008, NAT MED, V14, P701
  • [4] Baust JG., 2005, CELL PRESERV TECHNOL, V3, P1
  • [5] What Are the Biggest Challenges and Opportunities for Biorepositories in the Next Three to Five Years?
    Betsou, Fay
    Rimm, David L.
    Watson, Peter H.
    Womack, Christopher
    Hubel, Allison
    Coleman, Robert A.
    Horn, Liz
    Terry, Sharon F.
    Zeps, Nikolajs
    Clark, Brian J.
    Miranda, Lisa B.
    Hewitt, Robert E.
    Elliott, Gloria D.
    [J]. BIOPRESERVATION AND BIOBANKING, 2010, 8 (02): : 81 - 88
  • [6] Boggio A, 2005, COMP GUIDELINES BIOB
  • [7] Ethical aspects of human biobanks: a systematic review
    Budimir, Danijela
    Polasek, Ozren
    Marusic, Ana
    Kolcic, Ivana
    Zemunik, Tatijana
    Boraska, Vesna
    Jeroncic, Ana
    Boban, Mladen
    Campbell, Harry
    Rudan, Igor
    [J]. CROATIAN MEDICAL JOURNAL, 2011, 52 (03) : 262 - 279
  • [8] Bridging consent: from toll bridges to lift bridges?
    Budin-Ljosne, Isabelle
    Tasse, Anne Marie
    Knoppers, Bartha Maria
    Harris, Jennifer R.
    [J]. BMC MEDICAL GENOMICS, 2011, 4
  • [9] Trends in ethical and legal frameworks for the use of human biobanks
    Cambon-Thomsen, A.
    Rial-Sebbag, E.
    Knoppers, B. M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (02) : 373 - 382
  • [10] Assessing the impact of biobanks
    Cambon-Thomsen, A
    [J]. NATURE GENETICS, 2003, 34 (01) : 25 - 26